Back to News
Market Impact: 0.2
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
Source: PR Newswire
Healthcare & Biotech
The Phase 4 HARMONY IN DIVERSITY cohort is described as the first study of combined neurotoxin and filler treatment in adults taking GLP-1 medications. Participants reported statistically significant improvements in satisfaction with facial appearance and skin quality; the excerpt provides no effect sizes or further study details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Cabaletta Bio reports phase 1/2 data for autoimmune therapy
- Pacira’s final earnings in spotlight before $1.65B sale
- Organon earnings on deck as Sun Pharma merger awaits approval
- Street Calls of The Week
- 10 Apple products and features that transformed under Tim Cook's leadership
- CIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD